Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$208M |
| 2 |
Lowe's Companies
LOW
|
+$198M |
| 3 |
American Tower
AMT
|
+$161M |
| 4 |
Lennar Class A
LEN
|
+$150M |
| 5 |
British American Tobacco
BTI
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$208M |
| 2 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$177M |
| 3 |
Crown Castle
CCI
|
+$168M |
| 4 |
Walmart Inc
WMT
|
+$167M |
| 5 |
Entergy
ETR
|
+$157M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 13.75% |
| 2 | Technology | 13.18% |
| 3 | Healthcare | 11.51% |
| 4 | Industrials | 10.45% |
| 5 | Consumer Discretionary | 9.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1626
Stewart Information Services
STC
$2.12B
| $5.42M | 0.01% |
143,573
+26,735
| +23% | +$1.04M |
|
|
TSG
1627
DELISTED
The Stars Group Inc.
TSG
| $5.42M | 0.01% |
264,269
+171,380
| +184% | +$3.09M |
|
|
AEL
1628
DELISTED
American Equity Investment Life Holding Company
AEL
| $5.41M | 0.01% |
186,121
+173,171
| +1,337% | +$4.78M |
|
1629
Provident Financial Services
PFS
$3.06B
| $5.41M | 0.01% |
202,702
+52,503
| +35% | +$1.33M |
|
|
MZTI
1630
The Marzetti Company
MZTI
$3.2B
| $5.37M | 0.01% |
44,687
-148,994
| -77% | -$18M |
|
|
SCS
1631
DELISTED
Steelcase
SCS
| $5.36M | 0.01% |
+347,989
| New | +$4.77M |
|
|
ISBC
1632
DELISTED
Investors Bancorp, Inc.
ISBC
| $5.34M | 0.01% |
391,580
+39,329
| +11% | +$519K |
|
|
TRTN
1633
DELISTED
Triton International Limited
TRTN
| $5.33M | 0.01% |
+160,309
| New | +$5.52M |
|
1634
CALL
Vertex Pharmaceuticals
VRTX
$140B
| $5.32M | 0.01% |
35,000
-95,000
| -73% | -$14.3M |
|
|
IVAC
1635
DELISTED
Intevac Inc
IVAC
| $5.32M | 0.01% |
629,480
+310,881
| +98% | +$3.03M |
|
1636
PUT
Prudential Financial
PRU
$41.5B
| $5.32M | 0.01% |
50,000
-10,000
| -17% | -$1.07M |
|
|
1637
CALL
British American Tobacco
BTI
$122B
| $5.31M | 0.01% |
+85,000
| New | +$5.48M |
|
1638
Prudential
PUK
$35.3B
| $5.31M | 0.01% |
+114,232
| New | +$5.22M |
|
1639
Insmed
INSM
$27.1B
| $5.3M | 0.01% |
169,821
+156,229
| +1,149% | +$2.98M |
|
1640
iShares TIPS Bond ETF
TIP
$15.1B
| $5.29M | 0.01% |
+46,536
| New | +$5.3M |
|
1641
Children's Place
PLCE
$59.8M
| $5.28M | 0.01% |
44,694
-114,803
| -72% | -$12.3M |
|
1642
Celldex Therapeutics
CLDX
$3.24B
| $5.26M | 0.01% |
122,704
+112,385
| +1,089% | +$4.21M |
|
1643
Old National Bancorp
ONB
$9.82B
| $5.26M | 0.01% |
287,286
+263,200
| +1,093% | +$4.4M |
|
1644
Beazer Homes USA
BZH
$885M
| $5.24M | 0.01% |
279,847
+227,936
| +439% | +$3.47M |
|
|
ACRE
1645
Ares Commercial Real Estate
ACRE
$262M
| $5.24M | 0.01% |
393,754
+239,465
| +155% | +$3.14M |
|
|
TIME
1646
CALL
DELISTED
Time Inc.
TIME
| $5.24M | 0.01% |
+387,900
| New | +$5.21M |
|
1647
First Busey Corp
BUSE
$2.48B
| $5.23M | 0.01% |
166,834
+136,723
| +454% | +$4M |
|
1648
Lesaka Technologies
LSAK
$389M
| $5.22M | 0.01% |
536,049
+189,356
| +55% | +$1.83M |
|
1649
PTC Therapeutics
PTCT
$6.13B
| $5.21M | 0.01% |
+260,633
| New | +$5.1M |
|
|
MRTX
1650
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $5.21M | 0.01% |
445,709
+227,719
| +104% | +$1.32M |
|
Similar funds
Israel Englander's Q3 2017 Portfolio in Review
As of Q3 2017, Israel Englander held 4,198 positions worth $65.6B, up 17% from $56.1B the previous quarter. Its ten largest holdings account for 7.8% of the portfolio.
Israel Englander deployed $6.37B of net new capital in Q3 2017, opening 794 new positions and adding to 1,441 existing holdings. Its largest new stake was Northern Trust: 1,591,041 shares worth $146M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Gilead Sciences, an estimated $208M trimmed.
- Israel Englander's largest Q3 2017 buy was Northern Trust: 1,591,041 shares worth $146M.
- Israel Englander added most to Salesforce in Q3 2017, an estimated $208M increase.
- Israel Englander's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $208M.
- Israel Englander fully exited CONCHO RESOURCES INC. in Q3 2017, selling an estimated $177M.
- Israel Englander's ten largest holdings make up 7.8% of its $65.6B portfolio in Q3 2017.
- Israel Englander opened 794 new positions and closed 737 in Q3 2017.
- Israel Englander's portfolio value rose 17% quarter-over-quarter to $65.6B.
Based on Millennium Management's 13F filing for Q3 2017, filed 14 Nov 2017.